添加微信 添加微信
添加微信
首页: 全球医药政策

中国-Aastrom Research International

时间:2021-10-21 12:31:24 来源:康安医药咨询 作者:康安医药咨询

Astrom Research International (ARI) is a CRO and specialised consultancy focusing exclusively on the Chinese market. We turn to Western companies in the Life Science sector intending to conduct clinical research or set up operations in China. The strength of ARI lies in the combination of vast experience within clinical trials management, an extensive local contact network and cultural insight. All parts necessary to perform clinical research in China. We operate through a network of high quality university hospitals in all major Chinese cities and work cooperatively with key regulatory authorities on both provincial and national level. ARI has concluded agreements with multiple major hospitals in China in specified areas of cooperation. These agreements cover areas such as International Clinical M/C Trials in Chinese hospitals, GCP Training of Investigators and site Monitors, and Organisation of Conferences and Seminars in EU, US and China

Phone: 46708634909 E-mail: stefan@astromresearch.com
Web: http://www.astromresearch.com
Add:Room 2103, Dongbo Building, 168 Shangwen Rd, Shanghai

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章